Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study-Reference-Cited by-同舟云学术

Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study

Published:2022-07-06 Issue:11 Volume:54 Page:784-793
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Malvisi Lucio¹^ORCID,Yarraguntla Aparna²,Mortier Marie-Cécile³,Osman Karen⁴^ORCID,Cleary David W.⁴⁵,Sente Béatrice³,Pascal Thierry G.²^ORCID,Weynants Vincent²^ORCID,Clarke Stuart C.⁴⁶,Taddei Laura¹^ORCID,Wilkinson Tom M. A.⁴⁵⁶^ORCID,Devaster Jeanne-Marie³^ORCID,Devos Nathalie³^ORCID,Alnajar J.⁷,Anderson R.⁷,Aris E.²,Ballou W. R.⁸,Barton A.⁹,Bourne S.⁷¹⁰,Caubet M.²,Clarke S. C.⁷,Cleary D. W.⁷,Cohet C.²,Coombs N. A.⁷,Osman K.⁷,Devaster J.-M.³,Devine V.⁷,Devos N.³,Dineen E.⁹,Elliott T.⁷,Gladstone R.¹¹,Harden S.⁹,Jefferies J.⁷,Kim V. L.⁷⁹,Moris P.³,Ostridge K. K.⁷⁹,Pascal T. G.²,Peeters M.³,Schoonbroodt S.³,Sente B.³,Staples K. J.⁷⁹,Tuck A. C.⁷,Welch L.¹²,Weynants V.²,Wilkinson T. M. A.⁷⁹,Williams A. P.⁷,Williams N. P.⁷⁹,Woelk C.⁷,Wojtas M.⁷,Wootton S. A.⁹,

Affiliation:

1. GSK, Siena, Italy

2. GSK, Wavre, Belgium

3. GSK, Rixensart, Belgium

4. Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK

5. Southampton NIHR Biomedical Research Centre, University Hospital Southampton Foundation NHS Trust, Southampton, UK

6. Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK

7. University of Southampton, Southampton, UK

8. GSK, Rockville, MD, USA

9. University Hospital Southampton NHS Foundation Trust, Southampton, UK

10. Portsmouth Hospitals NHS Trust, Portsmouth, UK

11. Wellcome Sanger Institute, Hinxton, UK

12. Solent NHS Trust, Southampton, UK

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2022.2092648

Reference33 articles.

1. COPD and the microbiome

2. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study

3. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study

4. Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease

5. Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled corticosteroids and risk of lower respiratory tract infection withMoraxella catarrhalisin patients with chronic obstructive pulmonary disease;BMJ Open Respiratory Research;2023-08

2. Global Research Trends on the Link Between the Microbiome and COPD: A Bibliometric Analysis;International Journal of Chronic Obstructive Pulmonary Disease;2023-05